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I. Introduction
The elderly represent the most rapidly growing popula-
tion group in the United States. Approximately 26 million
people aged ::::65 years currently live independently, and
this number is estimated to increase by 20% during the next
decade. At present there are approximately 2.7 million peo-
ple in the United States aged ~85 years, the "oldest old";
this group is the fastest growing population segment and is
projected to increase by nearly sixfold, reaching almost 16
million by the year 2030. These dramatic demographic shifts
will engender profound consequences for our society, in-
cluding the need to markedly increase the funding for the
health care of this burgeoning elderly population.
Persons ~65 years currently consume over one-third of
all U. S. health care expenditures, although they constitute
only 12% of the population. Much of this cost is for treat-
ment of cardiovascular disease, the major cause of death
and disability in the elderly. The majority of patients with
coronary heart disease and its complications are >65 years.
The high and rapidly increasing share of health care needed
for the elderly has generated a dramatic growth in Medicare
expenditures, creating a virtual crisis for federal policy-
makers. Although the Medicare program is recognized as
our society's moral commitment to meet the health needs
of the elderly, debate continues as to how to meet the rapidly
escalating Medicare costs. It seems inevitable that medical
care will be rationed unless the U.S. public and its elected
representatives and leaders alter present priorities for allo-
cation of resources. The U.S. public and its elected rep-
resentatives and leaders must decide how much of our re-
sources we are willing to devote to health care in general
and health care for the elderly in particular. Regardless of
the total resources allocated for health care, its quality must
be maintained and its cost-effectiveness continually exam-
ined and reevaluated. The public should appreciate that es-
tablishment and maintenance of standards of care constitute
the unique capability and responsibility of the medical
profession. All other decisions can and should be shared,
but quality of care is an issue that must be decided by
physicians.
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Our goals for this Bethesda Conference were multiple
and our target audiences varied. Many recommendations
are societal and are directed both to the general public,
including the elderly, and to society's elected representa-
tives who formulate and promulgate public policy. Other
recommendations are designed to aid physicians and other
health professionals who care for elderly patients with car-
diac disease. Some recommendations are directed to the
scientific and research community, including the American
College of Cardiology.
II. General Issues
1) Characterization of Elderly Patients
The elderly are a highly heterogeneous group in all re-
spects except chronologie age; and chronologie age poorly
predicts functional capabilities. Individuals ~65 years of
age, with and without cardiovascular disease, vary widely
in their physical, behavioral, cognitive and emotional func-
tioning; severity of illness; and expectations from medical
care. A pervasive theme of this Conference is that physi-
ologic age, mental status, cognitive ability and the presence
of concomitant disease, rather than age itself, should be the
major determinants of the extent of the health care. Indi-
vidual attributes such as cthnicity, culture, prior health sta-
tus, gender and personality more significantly inftuence the
psychosocial and disability status of elderly patients with
cardiovascular disease than does chronologie age.
In general, older patients with cardiovascular disease do
not have excessive hypochondriasis when compared with
younger people. They are interested in preserving their health
and typically are able and willing to adhere to therapeutic
recommendations.
In 1985, persons aged 65 in the United States had an
average life expectancy of 15. I for men and 19.5 years for
women. Preventive approaches are warranted, because a
reduction in risk factors can be achieved even in individuals
of advanced age. Efforts to educate and motivate elderly
individuals to adopt favorable diet and exercise patterns are
worthwhile.
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2) Ethical Issues: Effect of High Technology on
Medical Care
One example of the ethical and moral dilemmas facing
society is the effect of technologic advances on medical
care. Many current diagnostic and therapeutic procedures
employ high technology such as electronic devices; new
drugs; lasers; nuclear, chemical and metallurgic technolo-
gies; and biotechnology. High technology also includes those
therapies that preserve patients in a " vegetative" state. from
which recovery is not anticipated, but in which death can
be averted for prolonged periods. Patients who formerly
would have died, now live to consume additional high tech-
nology medical and social resources. Some high technology
resources reduce costs or prolong useful life, or both; others
simply prolongexistence and cause the expenditure of social
resources perceived by some to be better used differently.
Whatever the result, allocations of resources must be de-
tennined. Decisions about the application of high technol-
ogy are often unsettling and uncomfortable-for example.
today it may be necessary to decide whether a patient lives
or dies, or, in some instances, seems suspended between
the two states.
Costs. The widespread application of high technology
for diagnosis and therapy may generate enormous expend-
itures that never previously existed, thereby creating finan-
cial problems despite the benefit to society in general and
the elderly population in particular. For example. ease of
application, durability and freedom from malfunction of
pacemakers promoted their widespread utilization and in-
creased overall societal costs. For an individual patient,
however, a cardiac pacemaker of longer life is a cost-saving
effect of high technology . The total estimated cost of car-
diovascular procedures in the United States in 1984 was
about $9 billion. These included Doppler velocity studies,
noninvasive imaging techniques, cardiac catheterization,
catheter and surgical electrophysiologic studies, coronary
thrombolysis. percutaneous transluminal coronary angio-
plasty (PTCA). catheter and surgical ablation of arrhyth-
mias, balloon valvuloplasty. implantable defibrillators and
cardiac transplantation. One-third or more of these proce-
dures were performed in the elderly. These represent trends
toward more invasive management. For example. the per-
formance of percutaneous transluminal coronary angioplasty
increased dramatically, from 26,000 to 46,000 to 106,000
from 1983 to 1985; in 1984. 26% of these procedures were
performed in the elderly.
Ethicalconsiderations. The increasing use of high tech-
nology in elderly patients poses other ethical considerations,
including informed consent for these highly complex pro-
cedures. The issue of informed consent is unique in caring
for elderly patients because of the possibility of decreased
competence to understand the advice given and to make a
voluntary choice. When diminished competence is recog-
nized, attempts should be made to eliminate or reduce re-
mediable causative factors. If this is not possible, the phy-
sician should be guided by knowledge of the patient' s prior
values and the family's opinion of what the patient would
want if able to make a choice. Ethical concerns also involve
decisions regarding limitations of diagnostic and therapeutic
measures, including the initiation and discontinuation of
critical care interventions, flu ids, nutrition and the like.
Other ethical concerns involve access of the elderly to spe-
cialized medical care; this ethical conflict is accentuated in
the case of diagnosis related group lDRG)-based funding
of health care.
The medical care system in the United States, based on
traditional American values, has primarily focused on the
care of the individual. But physicians are being forced to
confront a competingethic. A physician' s obligation to each
patient remains the provision of the best possible care-
care based on scientific knowledge, personal skills and hu-
manistic and reasonably efficient principles. An unsettled
matter is how physicians should balance their obligations
to their individual patients against their obligations to so-
ciety. There may be times when society's legitimate interests
in conserving limited resources come first; in these situa-
tions, the interests of patients will be compromised.
3) Government Action to Control Health Care Costs
To decrease the rising health care costs for the elderly.
the administration has decided to decrease the percentage
of government expenditures for Medicare. Congress be-
lieved that alterations in Medicare reimbursement would be
addressed through legislation. Instead, Federal regulatory
changes have been enacted to accomplish budget savings.
Further, services previously performed and funded by gov-
ernment have been increasingly shifted to the private sector
for payment. causing employers to assume health costs that
otherwise would have been borne by government. To try to
protect services to Medicare beneficiaries. yet control costs,
both physicians and hospitals arc being pressured. Medicare
regulations determine hospital reimbursement for services;
a prominent example are the DRGs, which provide payment
to hospitals on the basis of diagnosis rather than actual
services and expenditures. Further, legislated restrictions
are often not included in bills that have the tag' 'health."
For example, the ability of hospitals to provide services has
been further decreased by severe limitations on their access
to the continued use of tax-exempt bonds.
III. Medical Issues
This section highlights the differences in the contem-
porary diagnosis and treatment of cardiovascular disease in
the elderly as compared with a younger population. In gen-
eral, elderly patients are at increased risk of complications
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from diagnostic and therapeutic procedures and often have
different expectations of outcomes of their illnesses.
1) Medical Therapy
a) Drug therapy. Aging alters drug metabolism, drug
distribution and the renal excretion of drugs; these changes
are often reflected by altered plasma drug concentrations.
Age alone docs not enhance sehsitivity to drugs or reduce
the benefits of therapy, but may require changes in drug
dosage. Decreases in renal excretion and hepatic metabolism
occur commonly with aging, so that drug dosage has to be
chosen with great care in elderly patients and usually should
be decreased for drugs whose clearance is reduced with
agmg.
Because of the frequency with which elderly patients
receive multiple medications, often from several physicians.
they are particularly likely to be subject to drug interactions.
Recognized or unrecognized concomitant diseases may also
adversely affect the patient's response to cardiovascular drugs.
b) Nonpharmacologic therapy. Nutrition and physical
activity play important roles in maintaining cardiovascular
function in the elderly. Exercise can improve the physical
working capacity of sedentary elderly individuals. Weight
reduction can reduce blood pressure independently of di-
etary sodium restriction.
2) Surgical Therapy
Cardiac surgery should be undertaken for the same in-
dications as at a younger age, and the preoperative evalu-
ation is comparable; however, special consideration must
be directed to the mental and metabolic state of elderly
patients, in addition to their general physical condition .
Many surgical procedures have an increased risk of mor-
bidity and mortality in elderly patients predominantly be-
cause of cornorbidity. Therefore, before a surgical proce-
dure is recommended, it should be determined whether an
elderly patient can actively participate in the postoperative
management and is likely to have long-term benefit .
In general, the overall recovery period is longer and more
expensive than for younger patients. Time in an intensive
care unit is usually longer, and elderly patients require in-
creased nursing attention.
Comparable increased risk characteristics apply to non-
cardiac surgery . The high prevalence of asymptomatic coro-
nary heart disease in the elderly demands careful preoper-
ative clinical evaluation for its recognition and assessment
of severity.
3) Prevention
The major goal of preventive therapy is to decrease dis-
ability and dependency. Most risk factors for cardiovascular
disease, including hypertension, abnormal serum lipid lev-
els, impaired glucose tolerance, cigarette smoking, obesity
and physical deconditioning, are both highly prevalent and
modifiable in the aged. Cardiovascular profiles of standard
risk factors retain usefulness in older persons, defining risk
over a wide range. Although the elderly have shared in the
recent decline in mortality from coronary heart disease in
the United States, this decline has been less than in younger
patients.
Hypertension is a dominant remediable risk factor in the
elderly because of its high prevalence and sustained impact
in advanced age. Elevated systolic blood pressure confers
a substantial risk for all major cardiovascular diseases in
the elderly, irrespective of diastolic blood pressure. Glucose
intolerance or diabetes independently increases cardiovas-
cular risk .
Although total serum cholesterol level does not predict
cardiovascular disease in older persons, fractionation into
its low-density lipoprotein (LDL) and high-density lipopro-
tein (HDL) components restores the predictive value of lipid
levels.
4) Psychosocial Considerations
Physicians should assume cognitive and behavioral com-
petence in elderly patients until it is proved otherwise by
diagnostic screening or more comprehensive assessment.
Comprehensive psychosocial evaluation of older patients
with cardiovascular disease should include information about
the following: personality, including coping skills and re-
sources; mood and affect; cognition; functional status prior
to the acute illness; family and social support; and recent
life changes and circumstances . Expectations of therapy
should be ascertained.
Depending on the severity of cardiovascular symptoms ,
changes in the life style of elderly patients may be reflected
in day to day work habits, social and recreational activities,
relations with spouse and family, sexual function and even
personality.
5) Cardiovascular Changes of Aging
There is an increase in vascular stiffness. apparently due
to alterations in the vascular media . Despite the statistically
significant trend in the U.S . for arterial systolic blood pres-
sure to increase with age, there is a wide variation among
individuals. The intrinsic heart rate slows with aging and
there is reduced responsiveness to catecholamine stimula-
tion.
Progressive left ventricular hypertrophy with age occurs
concurrently with the rise in arterial systolic blood pressure.
The moderate myocardial hypertrophy of aging appears to
be a successful adaptation to maintain normal heart volume
and myocardial function in the presence of increased arterial
pressure . Alterations in the physical properties of the heart
prolong isovolumic relaxation which causes a decrease in
early diastolic left ventricular compliance.
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The cardiac output at rest decreases or is unchanged
with aging. The effect of age on the cardiac output with
exercise depends on the subjects selected for study and has
varied from normal to an attenuated augmentation. The
hemodynamic profile of elderly subject" during exercise
resembles that of younger subjects who exercise with beta-
adrenergic blockade. The explanation for the decline in the
peak oxygen uptake with age must take into account the 10
to 12% decline in skeletal muscle mass with age. Thus a
decline in central circulatory performance cannot be inferred
unless the effects of decrease in muscle mass or in the ability
to shunt blood to exercising muscles can be excluded. Cen-
tral circulatory function may not limit the peak oxygen up-
take with exercise in the elderly, even though the heart rate,
stroke volume or cardiac output at the time of exhaustion
are lower in older subjects.
6) Clinical Assessment
The history and physical examination remain the cor-
nerstones in assessing cardiovascular disease in elderly pa-
tients. Accurate evaluation of symptoms may be hindered
by the coexistence of multiple diseases, engendering diffi -
culty in attributing signs and symptoms to the cardiovascular
system. The mentalconsequences of illness, drugs and aging
may also complicate accurate assessment of the patient' s
cardiac problem.
The physical examination may be modified by age and
disease. For example, vascular stiffness may mask thechar-
acteristic abnormal carotid pulse contour of aortic stenosis.
Blood pressure should he obtained in the supine , sitting and
standing positions to elicit postural hypotension. Neurologic
examination should includean assessmentof cognitivefunc-
tion, with attention to mental depression.
Noninvasive cardiac diagnostic tests are important in the
elderly . because the history may be unreliable and the phys-
ical examination difficultto interpret. The electrocardiogram
(ECG) remains useful in predicting cardiovascular disease
in the elderly. Despite the decline in maximal aerobic ca-
pacity with age, exercise testing is safe and effective in the
evaluation of ischemic heart disease and of cardiac function
in elderly patients. The extent of rise in systolic blood pres-
sure during an exercise test appears to be the best single
predictor of lessened subsequent morbidity and mortality.
The echocardiogram appears to be of greater value than
the chest roentgenogram in assessing overall cardiac size .
Radionuclide ventriculography can provide a quantitative
assessment of ventricular function and, although more ex-
pensive. it is applicable to more elderly patients than is
echocardiography.
7) Coronary Disease
By age 80, 20% of elderly individuals have a clinical
diagnosis of coronary disease; at that age the prevalence is
equal in men and women. The clinical presentation of coro-
nary disease differs in elderly patients. Chest pain is less
frequently the presenting or prominent symptom of acute
myocardial infarction. Surgical procedures associated with
acute blood loss or hypotension. as well as transient isch-
emic attacks, stroke or other illness, often precipitate myo-
cardial infarction in the elderly.
ECG confirmation of acute infarct ion may be more dif-
fi cult in the elderly because of an increased frequency of
conduction disturbances, prior infarction and left ventricular
hypertrophy. Measurements of left ventricular function at
rest and with exercise, using radionuclide ventriculography
or two-dimensional echocardiography, do not reliably in-
dicate coronary heart disease and myocardial ischemia in
the elderly.
The general management of elderly patients with acute
myocardial infarction differs a little from that of younger
patients with fewexceptions. Primary ventricular fibrill ation
is less common in elderly patients with acute infarction and
adverse central nervous system effects from lidocaine arc
increased; thus routine use of prophylactic lidocainehas less
rationale in this age group. Congestive hean failure is more
common in elderly patients.
Not only is the in-hospital mortal ity higher for elderly
patients with acute myocardial infarction , but the I year
mortality of elderly survivors of acute myocardial infarction
is almost four times greater at 2 70 years than at 50 to 59
years. Elderly patients with infarction have an increased
incidence of multivessel disease and left main coronary ar-
tery stenosis. Consideration of coronary bypass surgery must
take into account the increased incidence of complications
of coronary angiography and the higher operative risk in
patients > 70 years; however, long-term survival after coro-
nary bypass surgery is excellent in specifi c subgroups of
elderly patients.
Medical therapy with vasodilator drugs such as nitrate
and calcium blockingcompounds (nifedipine) is more likely
to produce postural hypotension or impaired atrioventricular
(AY) conduction (verapamil and diltiazem). Elderly patients
derive equal benefit from the long-term administration of
beta-blocking drugs after myocardial infarction; the reduc-
tion in mortality and reinfarction is similar in patients aged
65 to 75 years and in younger patients.
8) Hypertension
Hypertension is common with advancing age, approach-
ing or exceeding 50% prevalence in the aging population.
The higher the systolic and diastolic pressures, the greater
the morbidity and mortality from coronary heart disease,
congestive heart failure, stroke, renal failure and intermit-
tent claudication. Therefore when the systolic blood pres-
sure is consistently> [60 mm Hg, Or the diastolic pressure
is :::::90 mm Hg, treatment by nonpharmacologic or phar-
macologic means, or both, is indicated.
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Nonpharmacologic means to reduce blood pressure are
suggested for individuals with diastolic pressures between
90 and 94 mm Hg. The three major nonpharmacologic ap-
proaches are a sodium-restricted diet, weight control and
moderation in alcohol consumption.
Pharmacologic therapy is safe and well tolerated in the
elderly. The Joint National Committee favored a diuretic as
initial treatment for elderly individuals. In other studies,
treatment of elderly patientswith beta-blockers anddiuretics
was equally effective. Others have suggested initiatingther-
apy in the elderly with an angiotensin-converting enzyme
inhibitor or a calcium blocking drug. Adverse effects of
antihypertensive drugs in the elderly may be minimized by
starting with lower doses and by checking blood pressure
in the upright position.
Patients whose systolic blood pressure is between 140
and 160 mm Hg, with a diastolic pressure <90 mm Hg,
have borderline isolated systolic hypertension. These pa-
tients should have their blood pressure measuredat 6 month
intervals. The risk of isolated systolic hypertension is suf-
ficient to justify cautious drug therapy if nonpharmacologic
therapy fails to lower the systolic blood pressure < 160mm
Hg, even though controlled studies to assess efficacy have
not been completed.
9) Valvular and Congenital Heart Disease
Severe calcific aortic stenosis is the most common val-
vular lesion that requires valve replacement in the elderly .
Because these patients usually have excellent results from
surgery (even when the preoperative ejection fraction is
reduced), although at a slightly higher surgical risk, it is
important to recognizethe disorderand to assessits severity.
A systolic ejection murmur, a fourth heart sound and left
ventricularhypertrophy commonly occur in the elderly from
causes other than aortic stenosis. Noninvasive and invasive
tests are often necessaryto assess the presenceanddetermine
the severity of aortic stenosis in an elderly patient. Doppler
velocity recordings are useful in this regard.
Common causes of mitral regurgitation in the elderly
include coronary artery disease and its complications, myx-
omatous degeneration of the mitral valve cusps resulting in
mitral valve prolapse and mitral annular calcification. The
diagnosis of mitral regurgitation can usually be made by
cardiac auscultation; two-dimensional echocardiography and
echo-Doppler studies are useful in assessing etiology and
severity.
Most elderly patients require cardiac catheterization and
angiography before valvular surgery. Selective coronary
arteriography can identify the need forconcomitantcoronary
bypass surgery or the presence of inoperable coronary dis-
ease and its attendant increase in surgical risk.
In the elderly patient with valvular or congenital heart
disease, the clinical pictureof infectiveendocarditis is more
likely to be obscure or atypical. TIle high mortality of in-
fective endocarditis in the elderly may be related to late
diagnosis and. thus, late treatment.
10) Pulmonary Heart Disease
Ventilatory function and pulmonary diffusing capacity
decline progressively and nonuniformity of lung function
increases progressively after age 35. The decrease in pul-
monary vascularcompliancewith aging mayaccentuate pul-
monary hypertension in older patients.
Pulmonary embolism is common in geriatric patients in
whom risk factors for this condition abound (sedentary life-
style, prolonged bed rest, cardiopulmonary disease). The
diagnosis of pulmonary embolism in the elderly is compli-
cated by the decreased specificity of isotopic lung scanning;
areas of decreased lung perfusion may be present even in
the absence of embolic disease, rendering this test of lesser
diagnostic value.
Older patients with chronic obstructive pulmonary dis-
ease have a higher mortality, in part related to a high rate
of complicating overt or clinically unrecognized cardiovas-
cular problems. Therapeuticproblemsmay arise when treat-
ing patients who have both cardiac and pulmonary disease,
a common combination in elderly patients. Nonselective
beta-blockers given for hypertension or coronary disease
may induce bronchospasm; beta-blocking agents and the-
ophylline used in patients with chronic obstructive pulmo-
nary disease may have adverse effects on cardiac function
and even induce arrhythmias, particularly if the dosage is
not carefully controlled.
Elderly patients with hypoxemia respondas well as youn-
ger individuals do to low flow oxygen therapy; the rec-
ommendations of the Nocturnal Oxygen Therapy Trial Group
are applicable to the elderly.
Regular graded exercise minimizes disability in patients
withchronicobstructive pulmonary disease and can improve
their quality of life.
J1) Arrhythmias
Symptoms caused by arrhythmias and conduction dis-
turbances are the same at all ages. Ambulatory ECG re-
cording is the most useful diagnostic technique to correlate
symptoms with spontaneous arrhythmias.
Both tucltyarrhythmias and bradyarrhythmias may result
in syncope. This symptom may occur in up to 30 to 50%
of presumably healthy elderly adults and remains unex-
plained in about one-third of these individuals. The in-
creased incidence of syncope in the elderly is due, in part.
to the increased prevalence of symptomatic sick sinus syn-
drome. fascicular blocks and ventricular tachyarrhythmias,
as well as to the use of predisposing drugs, for example,
beta-blockers. vasodilators. calcium blockers and antihy-
pertensive drugs.
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The sick sinus syndrome and trifascicular block are pre-
dominantly geriatric problems. The prevalence of brady-
cardia is increased because of both impaired sinoatrial node
function and altered autonomic tone. The anatomic sub-
strates include fi brosis of the sinoatrial node with decrease
in the number of pacemaker cells; degeneration and fibrosis
of the central fibrous body and summit of the ventricular
septum. and fibrosis andcalcification of the mitral and aortic
valve rings and leaflets.
Asymptomatic elderly patients with the sick sinus syn-
drome do not require treatment: this may also be true for
patients with brief sporadicpalpitations or dizziness. Before
pacemaker insertion for symptomatic sinus node dysfunc-
tion. it should be ascertained that medications have not
contributed to the sinus node dysfunction. Pacemaker ther-
apy is effective in treating the syncope of the sick sinus
syndrome; there is an increasing trendto insertdual-chamber
pacing mode (DOD) pacemakers. This type of pacemaker
is indicated primarily for patients who are ambulatory and
physically active. reserving ventlicular-inhibited pacing mode
(VVI) pacemakers for patients with a shorter anticipated life
span who are sedentary or immobilized. Pacemakers can
prolong life and improve the quality of life in appropriately
selected geriatric patients.
Asymptomatic ventricular ectopic activity in an elderly
patient does not generally require therapy.
Antiarrhythmic drug therapy is potentially hazardous.
especially in the elderly. Elderly patients are likely to be
taking many medications that may interact with antiarrhyth-
mic drugs. and antiarrhythmic drugs generally have an in-
creased elimination half-life in the elderly because of their
decreased rate of elimination or hepatic metabolism. or both.
Further. elderly patients are more likely to have disease of
the cardiac conduction system or left ventricular systolic
dysfunction that may be exacerbated by antiarrhythmic drug
therapy.
/ 2) Heart Failure
The prevalence of heart failure increases exponentially
with age. It is more common in men and has a poor prog-
nosis: fewer than half the patients survive 5 years after
diagnosis. Specific factors precipitating heart failure are more
common and important in elderly patients. mandating at-
tention to their detection and correction.
It is often difficult 10 clinically differentiate cardiac f rom
pulmonary causes of excessive breathlessness . Pulmonary
rales arc not a reliable sign of left heart failure because of
the frequency of chronic pulmonary disease in the elderly.
Many patients thoughtto have exertional dyspnea secondary
to heart disease may have dominant pulmonary disease.
Further, the manifestations of heart failure may be masked
or mimicked by the sedentary life-style of many older pa-
tients.
Decreased ventricular compliance and elevation of the
pulmonary capillary pressure may produce pulmonary
congestion and clinical manifestations of heart failure in the
elderly patient with preserved systolic function. Decreased
ventricular compliance is a likely cause of heart failure in
the elderly patient with minimal or no cardiac enlargement,
particularly when hypertension. hypertrophic cardiomy-
opathy or other causes for left ventricular hypertrophy.arc
present. Noninvasive techniques for evaluating cardiac
function have improved considerably the recognition of heart
failure in the elderly. as well as helping determine if systolic
or diastolic dysfunction predominates. Measured left ven-
tricular systolic functioncorrelates poorlywith symptomatic
heart failure and exercise capacity,
Treatment of heart failure is similar to that in younger
individuals; improvement in exercise capacity can be ex-
pected after treatment. Exercise trainingcan furtheraugment
exercise tolerance because of peripheral circulatory and
skeletal muscle adaptations; and may improve quality of life
in patients with chronic congestive heart failure of all ages.
13 ) Ca rdiomyopathy
Congestive dilated cardiomyopathy is less common in
the elderly. In large series of patients > 65 years with
congestive heart failure. approximately 10% are classified
as having dilated cardiomyopathy. Hypertrophic cardio-
myopathy is also less common in the elderly. When present.
free wall hypertrophy is often equal to that of the septum.
Most natural history studies emphasize the rarity of sudden
death in elderly patients with hypertrophic cardiomyopathy.
II is unclear if senile amyloidosis is of any fun ctional
clinical significance, although atrial fibrillation may coexist
when there are large atrial amyloid deposits.
Increasing numbers of elderly patients currently develop
postoperative restrictive cardiomyopathy , presumably sec-
ondary to coronary artery bypass surgery or other surgical
causes of pericarditis.
Recommendations
I . PubliciLegisla tive Policy
What expectations should society. and the elderly as a
component of our society, have for health care? A national
policy should be developed in a rational and coordinated
manner with three goals in mind: quality, access and cost-
effectiveness. A balance must be achieved between the ac-
cess to affordable quality care when it is likely to be ben-
eficial, concern for the patient' s quality of life and the need
fix fi scal responsibility in view of the finite limitations to
the financial resources available for health care, There is a
need to educate the public and thereby encourage public
involvement in the complex issues involved in weighing
health care needs of individual patients when they may
86A WENGER ET AL.
CARDIOVASCULAR DISEASE IN THE ELDERLY
lACC Vol. 10. No.2
August 1987:80A-87 A
conflict with those related to limited funds for health care.
A first step in public education is to confront ethical issues
as such and not disguise them behind debates about cost-
effective and cost-beneficial health care delivery systems.
The question should be raised as to whether the fixed fees
to hospitals and the Medicare predetermined hospital stays
arc compatible with quality care.
High technology is so integrated into medical practice
as to be indistinguishable from other aspects of medical
care, but is costly. raising questions as to how much care
can and should be supported by society. If the application
of high technology will be limited by age, then a permanent
second class elderly patient population will be established
and this is an ethically unacceptable change.
Society must be aware of and address:
J) What justifies present priorities that decrease health care
resources and lead to debates about cost-benefit and cost-
effectiveness?
2) What obligations do we have to provide for health care
needs of the elderly? Are we prepared to limit or abandon
provisions included in the early Medicare years?
3) What obligations do the elderly have to meet their health
care costs? Are these the same for the impoverished as
for the more affluent elderly?
4) Is the public policy shifting the costs of care and the
. 'informal" care needs of the elderly to their families?
Is this reasonable or excessive in view of competing
demands on filial responsibility?
5) Have policy changes adversely affected the access of the
elderly with cardiovascular disease to care and adversely
affected the quality of this care?
6) As a society committed to justice and fairness, can we
ask physicians to deny access to care or offer less than
quality care solely on the basis of age or cost?
7) Which elderly will be denied access to care or receive
a decreased quality of care if the above obtains? Will it
be based on diagnosis or other criteria? Is there justifi-
cation for such selective changes?
8) What will be the ethical impact of such changes on the
physician-patient relation? Should physicians accept such
changes? Should society accept such changes?
II. Tasks for the American College of Cardiology
The American College of Cardiology should encourage
involvement of the public in helping their elected represen-
tatives develop health care policies for the elderly. A focus
for this debate is how the traditional ethic of medicine ap-
pears to be directly challenged by economic constraints on
health care for the elderly, constraints imposed both by the
public and increasingly by the private sector.
Adequate definitions and descriptors of quality cardio-
vascular care must be developed, with mechanisms for pe-
riodic reevaluation of these criteria. The American College
of Cardiology should form Task Forces to address these
issues for elderly patients, possibly organized on a DRG
classification basis, but also addressing variations in severity
of illness and case complexity (cornorbidity).
III. Physician Attitudes and Practices
The goals ojtreatment in the elderly are identical to those
in younger patients and include improvement in cardiovas-
cular performance, reduction of morbidity, increase in func-
tional capacity to enable an independent life-style and a
prolongation of life. The dominant health objectives for the
elderly should be the prevention of enfeeblement, disability
and dependency, rather than an extension of life, regardless
of quality.
The view of the elderly as senile, disabled, unproductive
and resistant to change is unfounded. Further, inappro-
priately low expectations for recovery and restoration of
functional status by the patient, the patient's family or the
physician may limit optimism and adaptive behaviors in the
elderly. Physicians should encourage active participation by
older patients with cardiovascular disease in their overall
health care and should help patients set realistic goals. Phy-
sicians should recognize that incentives for recovery and
activity resumption after a cardiovascular illness differ in
the elderly; return to work often is not a goal. The physician
should also provide both education and emotional support
for older patients and their families.
Prevention. Preventive measures are ideally initiated
early in life to reduce the ultimate burden of cardiovascular
disease, but such measures instituted in the aged should not
he considered valueless. Preventive measures may ulti-
mately restrain costs. These include moderate sodium re-
striction with maintenance of dietary calcium. Physicians
should also encourage reasonable patterns of activity. in-
cluding moderate regular dynamic exercise, particularly
walking, for its beneficial physiologic, metabolic and psy-
chologic responses. Limiting immobilization and encour-
aging activity help prevent leg deep vein thrombosis and
pulmonary embolism. Physicians should also encourage so-
cial activities for older patients with cardiovascular disease.
Because of the high incidence and prevalence of hyperten-
sion in the elderly population, blood pressures of all elderly
individuals should be rechecked on an annual basis. even
if initially within the normal range.
Most trials ofdrug efficacy for the secondary prevention
ofcardiovascular disease have excluded patients>70 years.
Therefore it is uncertain that results in younger patients can
be extrapolated to the elderly. Future trials should include
elderly patients.
Little is known about the cost-effectiveness ofpatterns of
health care delivery in the elderly. We must ascertain the
effect of shortened hospital lengths of stay on the morbidity
and mortality of patients with acute myocardial infarction
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and congestive heart failure. These assessments are ham-
pered by lack of definitions of " quality" cardiovascular
care. The cost-effectiveness of extended care in a skilled
nursing facility or at home rather than in the hospital has
to be evaluated.
Drug therapy. A combination of the physiologic changes
of aging and disease in other organ systems, as well as
polypharmacy, increases the likelihood of drug toxicity and
adverse drug effects in elderly patients. Increasing attention,
therefore, must be directed to decreasing the risk of un-
wanted drug effects in the elderly.
IV. Research
General. Much basic science and clinical research is
needed to provide quality cardiovascular care for elderly
persons. Although elderly patients use 30% of all prescrip-
tion drugs, there is a relative lack of information about the
efficacy and disposition of cardiovascular drugs in this pop-
ulation. Elderly patients should be included in studies of
experimental drugs currently being tested for the manage-
ment of cardiovascular diseases.
A further major impediment in the drug treatment of
elderly patients is inadequate information about responses
in the elderly to a large number of already marketed drugs
currently used to treat elderly patients, including potential
adverse cardiovascular effects of noncardiac drugs.
Nutritional requirements must be defined for elderly per-
sons. We must also determine benefits and hazards of al-
terations of diet and of exercise in the elderly, and evaluate
alternate types of exercise for patients with limited ambu-
lation.
Coronary artery disease. Scientific information re-
garding the recognition of and Current treatmentapproaches
to the elderly coronary patient are inadequate or lacking.
For example, few prospective studies have assessed risk
stratifi cation during or after acute myocardial infarction in
patients > 70 years, as compared with younger patients.
Most secondary prevention studies, both of risk reduction
and of drug therapy after myocardial infarction, have in-
cluded few or no elderly patients; thus the results may not
apply to elderlypatients. Alternatives to bicycleor treadmill
exercise testing are needed to evaluate patients unable to
perform these tests.
Pulmonary disease. Relatively little is known about the
effects of age and aging on pulmonary arterial pressures in
healthy individuals. It is also unknown whether the pul-
monary circulation responds differently to left ventricular
failure or mitral valve disease, or both, in older patients
than it docs in younger patients. Other than anecdotal in-
formation. little is known about the effect of age on a variety
of pulmonary conditions or even how commonly some of
these illnesses occur in an elderly population.
Anticoagulation. The risk-benefi t ratio of anticoagula-
tion in the elderly has not been established. Recommen-
dations for routine use of chronic anticoagulation in the
elderly patient with nonvalvularatrial fibrillation mustawait
the results of ongoing clinical trials.
